Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 58.60%-96.59K | -199.12%-758.77K | 9.53%-438.94K | -297.76%-1.46M | -33.65%-492.82K | -50,817.17%-233.3K | -1,409,150.00%-253.67K | -2,695,405.56%-485.19K | -511,430.56%-368.3K | -368.73K |
| Net income from continuing operations | 55.30%-558.29K | -350.18%-1.25M | -257.17%-955.26K | -1,113.35%-2.84M | -633.87%-1.04M | -3,556.48%-1.25M | -860.33%-277.55K | -833.63%-267.45K | -97.30%-233.78K | ---142.08K |
| Operating gains losses | --21.39K | ---- | ---- | --30.81K | ---- | ---- | ---- | ---- | ---- | ---- |
| Asset impairment expenditure | ---- | ---- | ---- | --704.42K | --35.67K | ---- | ---- | ---- | --0 | --0 |
| Remuneration paid in stock | -48.12%183.61K | 397.61%403.59K | --433.35K | --577.01K | --141.95K | --353.95K | --81.11K | --0 | --0 | --0 |
| Other non cashItems | --81.26K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | 3,374.61%230.96K | 227.03%72.7K | 138.10%82.96K | 144.15%59.39K | 250.64%341.42K | -120.37%-7.05K | -298.13%-57.23K | -860.59%-217.74K | -213.59%-134.52K | ---226.65K |
| -Change in receivables | -326.88%-100.88K | -271.00%-44.56K | -43.97%-25.63K | -589.04%-75.57K | -246.16%-22.13K | -1,290.94%-23.63K | -731.28%-12.01K | -1,143.89%-17.8K | -92.08%-10.97K | ---6.39K |
| -Change in prepaid assets | -544.87%-173.21K | 102.47%4.28K | 94.91%-12.83K | ---30K | --356.24K | --38.93K | ---173.41K | ---251.76K | --0 | --0 |
| -Change in payables and accrued expense | 2,359.20%505.04K | -11.86%112.99K | 134.30%121.41K | 233.52%164.97K | 103.32%7.31K | -161.56%-22.36K | 322.69%128.19K | 72.39%51.82K | -199.53%-123.55K | ---220.25K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 58.60%-96.59K | -199.12%-758.77K | 9.53%-438.94K | -297.76%-1.46M | -33.88%-492.82K | -137,134.71%-233.3K | -1,409,150.00%-253.67K | -2,695,405.56%-485.19K | -511,430.56%-368.3K | ---368.1K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1,510.16%-2.39M | -3,037.84%-221.95K | 85.77%-43.78K | 21.42%-166.58K | 232.89%281.74K | -148.13K | 7.56K | -307.74K | -212K | -212K |
| Net PPE purchase and sale | --0 | --0 | --0 | 118.29%38.78K | 254.23%326.96K | ---88.18K | --58.18K | ---258.18K | ---212K | ---212K |
| Net other investing changes | -7,862.31%-2.39M | -175.30%-221.95K | 11.66%-43.78K | ---205.36K | ---45.22K | ---29.96K | ---80.62K | ---49.56K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -1,919.05%-2.39M | -888.88%-221.95K | 85.77%-43.78K | 21.42%-166.58K | 232.89%281.74K | ---118.13K | ---22.45K | ---307.74K | ---212K | ---212K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 2.35M | 2.29M | 200K | -94.68%128.04K | -83.32%128.04K | 0 | 0 | 0 | 2.41M | 767.5K |
| Net issuance payments of debt | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net common stock issuance | --2M | ---- | ---- | -99.46%5.4K | --5.4K | --0 | ---- | ---- | --1M | --0 |
| Proceeds from stock option exercised by employees | ---10K | --539.5K | --200K | ---- | ---- | --0 | --0 | --0 | --1.41M | ---- |
| Net other financing activities | ---- | ---- | ---- | -91.28%122.64K | ---- | ---- | ---- | ---- | --1.41M | --767.5K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --2.03M | --2.29M | --200K | -94.68%128.04K | -83.32%128.04K | --0 | --0 | --0 | --2.41M | --767.5K |
| Net cash flow | ||||||||||
| Beginning cash position | 77.90%1.35M | -96.15%39.78K | -82.34%322.5K | 568,753.27%1.83M | -75.25%405.54K | 265,505.96%756.98K | 340,852.81%1.03M | 568,753.27%1.83M | -18.32%321 | --1.64M |
| Current changes in cash | -29.58%-455.38K | 573.31%1.31M | 64.34%-282.72K | -182.35%-1.5M | -144.31%-83.05K | -121.45%-351.43K | -1,533,844.44%-276.11K | -4,405,077.78%-792.93K | 2,535,791.67%1.83M | --187.4K |
| End cash Position | 119.77%891.26K | 77.90%1.35M | -96.15%39.78K | -82.34%322.5K | -82.34%322.5K | -75.25%405.54K | 265,505.96%756.98K | 340,852.81%1.03M | 568,753.27%1.83M | --1.83M |
| Free cash from | 69.96%-96.59K | -288.14%-758.77K | 40.95%-438.94K | -206.08%-1.78M | 11.07%-515.86K | -189,004.12%-321.48K | -1,085,938.89%-195.49K | -4,129,727.78%-743.37K | -805,875.00%-580.3K | ---580.1K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.